MacroGenics (NASDAQ: MGNX) CEO converts RSUs and disposes shares at $1.81
Rhea-AI Filing Summary
MacroGenics (MGNX) President and CEO Eric Blasius Risser reported multiple equity award transactions in early February 2026. On February 7, 2026, 6,668 restricted stock units (RSUs) converted on a one-for-one basis into common stock, increasing his direct holdings to 62,657 shares before a 2,575-share disposition at $1.81 per share, leaving 60,082 shares.
On February 8, 2026, a further 11,166 RSUs converted into common stock, taking his direct common stock position to 71,248 shares before a 4,311-share disposition at $1.81 per share, resulting in 66,937 common shares directly owned. Following these transactions, he held 13,332 RSUs from a February 7, 2025 grant of 20,000 units and 11,166 RSUs from a February 8, 2024 grant of 33,500 units, each vesting in three equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 11,166 | $0.00 | -- |
| Exercise | Common Stock | 11,166 | $0.00 | -- |
| Tax Withholding | Common Stock | 4,311 | $1.81 | $8K |
| Exercise | Restricted Stock Unit | 6,668 | $0.00 | -- |
| Exercise | Common Stock | 6,668 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,575 | $1.81 | $5K |
Footnotes (1)
- Restricted stock units convert into the Company's stock on a one-for-one basis. On February 7, 2025, the reporting person was granted 20,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. On February 8, 2024, the reporting person was granted 33,500 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.
